A bipartisan bill that plans to allow a tax credit for expenses of contracted research — often done by Contract Research Organizations (CROs) — has been introduced in the U.S. House of Representatives and was quickly hailed by the industry.
Former FDA Commissioner Robert Califf and his successor Scott Gottlieb have applauded President Donald Trump’s decision to keep Francis Collins as head of the National Institutes of Health (NIH), although it may be a poisoned chalice given that billions of dollars in cuts could be on the way.
Researchers at ITMO University in St. Petersburg, Russia, have developed a magnetically controlled treatment designed to dissolve blood clots. The method looks to be a promising solution to some of the complications associated with enzyme-based thrombolytic drugs.
After President Donald Trump’s blueprint budget in March looked to cut $5.8 billion from the National Institutes of Health (NIH), his administration is now looking for an immediate $1.2 billion in cuts from the medical research network in FY 2017.
US Food and Drug Administration (FDA) Commissioner Scott Gottlieb was in the hot seat on Thursday to defend President Donald Trump’s budget plan to the House appropriations subcommittee, though the conversation quickly dovetailed away from the billion-dollar user fee increase proposed, and revealed that FDA as of Thursday is no longer subject to a federal hiring freeze.
President Donald Trump’s administration has released a breakdown of its attempts to cut back on healthcare and research spending across the government, with proposed cuts to governmental biomedical research centers and the drugs regulator laid down in the fleshed-out budget.
IBM Research in Australia is partnering with Melanoma Institute Australia on identifying melanoma using cognitive technology. The team will conduct research to build on IBM’s work with MoleMap. MoleMap uses visual analytics to analyze more than 40,000 data sets that include images and text.
A “bionic” cardiac patch has been developed by researchers at Harvard. Charles Lieber, Chair of the Department of Chemistry and Chemical Biology at Harvard, and Postdoctoral Fellow Xiaochuan Dai co-authored a study regarding the cardiac patch, which was published in Nature Nanotechnology.
China’s FDA published (Chinese) a slate of suggested amendments to its foreign drug registration rules on Friday, March 17, 2017, aiming to speed up approvals, and pharma companies quickly hailed the changes.
The US Food and Drug Administration (FDA) on Friday, June 2, 2017 notified medical device labelers that it is extending the compliance dates for certain unique device identifier (UDI) requirements for Class I and unclassified devices.